Workflow
基因编辑猪肝脏
icon
Search documents
全球首例!为啥又是“二师兄”立功 南都新知
Nan Fang Du Shi Bao· 2025-08-28 09:27
Core Viewpoint - The article discusses the successful transplantation of genetically edited pig lungs into a brain-dead human, marking a significant advancement in xenotransplantation, which aims to address the global organ shortage crisis [1][5][18]. Group 1: Background and Importance of Xenotransplantation - Approximately 2 million people worldwide require organ transplants each year, but only about 10% receive suitable organs, highlighting the critical shortage of transplantable organs [5]. - Xenotransplantation, particularly using pig organs, is considered a promising solution to the organ shortage problem [5][9]. Group 2: Research and Development - The research team led by Professor He Jianxing from Guangzhou Medical University successfully transplanted a genetically edited Bama pig's left lung into a brain-dead patient, maintaining ventilation and gas exchange for 9 days [5][18]. - Since 2021, several cases of pig-to-human organ transplants have been reported globally, involving various organs such as hearts, kidneys, and livers [7]. Group 3: Advantages of Using Pigs - Pigs are preferred over primates for organ donation due to their abundant resources, smaller size, high survival rates, and genetic stability, along with significant anatomical and physiological similarities to humans [9][10]. - The evolutionary distance between pigs and humans reduces the risk of zoonotic diseases and ethical concerns associated with using primates [9]. Group 4: Challenges in Xenotransplantation - Despite the advantages, xenotransplantation faces challenges such as cross-species rejection and the risk of infections, which have historically hindered research progress [10][18]. - Recent advancements in gene editing technologies, such as CRISPR/Cas9, have enabled the development of genetically modified pigs that minimize immune rejection and viral infection risks [10][12]. Group 5: Clinical Trials and Future Prospects - Currently, xenotransplantation trials are primarily conducted in China and the United States, with significant milestones achieved in heart and kidney transplants [14][16]. - The recent lung transplant case represents a critical step towards clinical applications, although experts emphasize the need for cautious progression through further trials and research [18][19].
Nature Medicine:世界首例!我国学者成功将基因编辑猪肺移植到人体内
生物世界· 2025-08-26 00:00
Core Viewpoint - The article discusses significant advancements in xenotransplantation, particularly focusing on the successful transplantation of genetically edited pig organs into human patients, highlighting the potential to alleviate organ shortages in humans [3][4][5]. Summary by Sections Breakthroughs in Xenotransplantation - In October 2021, NYU Langone Medical Center performed the first transplantation of a genetically edited pig kidney into a brain-dead woman [3]. - In January 2022, the University of Maryland conducted the first live transplantation of a genetically edited pig heart, with the patient surviving for approximately two months [3]. Recent Research on Pig Lung Transplantation - In March 2025, a team from Xijing Hospital published a paper in Nature, reporting the first successful transplantation of a genetically edited pig liver into a brain-dead patient, with the organ functioning for 10 days [4]. - In August 2025, a study published in Nature Medicine documented the world's first successful transplantation of a genetically edited pig lung into a brain-dead human, with the lung surviving for 9 days and functioning properly [5][4]. Genetic Modifications and Challenges - The pig lung used in the transplantation was genetically modified by deleting three "dangerous" genes (GTKO, CMAH, B4GALNT2) and adding three protective human genes (hCD46, hCD55, hTBM) to mitigate immune rejection [7][9]. - During a 216-hour monitoring period, the transplanted pig lung maintained vitality and function without signs of hyperacute rejection or infection, although complications such as severe edema and antibody-mediated rejection were observed [9][10]. Future Directions and Considerations - The study indicates that further genetic modifications may be necessary to improve outcomes, particularly in addressing coagulation disorders and enhancing graft survival [11][12]. - The complexity of lung transplantation poses greater challenges compared to other organs, necessitating ongoing preclinical research to overcome these barriers [12]. China's Leadership in Xenotransplantation - Chinese scientists are at the forefront of xenotransplantation research, having completed the world's first human transplant of genetically edited pig liver and lung, as well as a kidney transplant with a patient surviving for nearly six months [12].